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A B S T R A C T
The primary goals of this study were to adapt the Quality of Life in Epilepsy Inventory – 31 items (QOLIE-31) ques-
tionnaire to the Croatian language and to assess the translated questionnaire’s psychometric properties. Translation/
retranslation of the English version of the QOLIE-31 was done, and all steps for cross-cultural adaptation process were
performed properly by an expert committee. Later, QOLIE-31 questionnaires and previously validated Short Form-36
(SF-36) outcome instruments were given to 200 patients with epilepsy. 172 patients (86%) responded to the first set of
questionnaires, and 114 of the first time respondents (66%) returned their second survey. The two measures of reliability
as internal consistency and reproducibility were determined by Cronbach a statistics and intraclass correlation coeffi-
cient, respectively. Concurrent validity was measured by comparing with a SF-36 questionnaire, and measurement was
made using the Pearson correlation coefficient (r). The study demonstrated satisfactory internal consistency with high
Cronbach a values for all of the corresponding domains (seizure worry 0.84, medication effects 0.80, emotional well-be-
ing 0.73, energy/fatigue 0.76, cognitive functioning 0.71, social functioning 0.77, overall quality of life 0.65). The intra-
class correlation coefficient for six domains of QOLIE-31 questionnaire demonstrated excellent test/retest reproducibility
(ICC  0.75), and good test/retest reproducibility (ICC 0.71) in one domain (cognitive functioning). Considering concur-
rent validity, three domains had excellent correlation (r=0.75–1), while 11 had good correlation (r=0.50 to 0.75), and 3
had moderate correlation (r=0.25–0.50). This study demonstrated that, if measures are to be used across cultures, the
items must not only be translated well linguistically but also must be culturally adapted to maintain the content validity
of the instrument at a conceptual level across different cultures. Croatian version of QOLIE-31 will be a valuable contri-
bution to outcome measurement in epilepsy patients, particularly in the context of treatment trials, but als in a wider re-
search context.
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Introduction
The chronic nature of epilepsy often results in long-
-term relationships among the neurologist, the patient,
and the patient’s family. When treating a patient with epi-
lepsy it is important to evaluate the degree to which epi-
lepsy affects their life. Persons with chronic health disor-
ders are at risk of impaired health related quality of life
(HRQOL)1. Because the epilepsy has a substantial impact
on health (e.g. side effects of anticonvulsant therapy, life-
style restrictions, physical difficulties, psychosocial diffi-
culties, perceived stigmatization) self-reported physical
and mental HRQOL measures are useful in gauging the
impact of epilepsy on persons with the disorder2–4.
One of the methods to define and monitor the impact
of epilepsy on patient’s life is to ask patients to record
their feelings on questionnaires5. The focus of these de-
mands is aimed at assessing »quality of life« (QOL) as a
measure of outcome in clinical practice and/or drug tri-
als, along with evaluating the allocation of health care re-
sources. With the introduction of the health related QOL
questionnaires, it is possible to understand the percep-
tion of the patient of his/her current condition and the
results of the applied treatment. Health care providers
and the pharmaceutical industry have been showing in-
creasing interest in QOL, because without equally re-
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fined QOL measurements, a clear and comprehensive
evaluation of efficacy of new drugs – or new medical in-
terventions – is not possible.
QOL questionnaires use a multidimensional approach;
the concept of QOL assessment has led to development of
generic questionnaires, designed to assess health status
among patients with different health conditions and dis-
eases, and disease-specific questionnaires to evaluate
specific areas of concern to patients6.
There are few questionnaires designed specifically for
patients with epilepsy: Liverpool Health Related Quality
of Life Battery (Liverpool HRQOL); Washington Psych-
osocial Seizure Inventory (WPSI); Epilepsy Surgery In-
ventory (ESI-55); Quality of Life in Epilepsy Inventory –
89 items (QOLIE-89) and Quality of Life in Epilepsy In-
ventory – 31 items (QOLIE-31)7–11.
There is also Quality of Life in Epilepsy Inventory –
10 items (QOLIE-10), but this questionnaire is used only
for screening purposes12.
The aim of the original QOLIE-31 questionnaire, de-
veloped by Cramer et al., was to facilitate – from a pa-
tient based point of view – the assessment of the outcome
during the treatment of patients with a simple, practical,
epilepsy-specific instrument. The QOLIE-31 is a self-
-completed questionnaire designed for adult epileptic
patients (18 years or older). It was derived from a previ-
ously mentioned longer instrument, the QOLIE-89, cre-
ated by the QOLIE Development Group in 1993. It con-
tains seven subscales which address the following aspects:
emotional well-being, social functioning, energy/fatigue,
cognitive functioning, seizure worry, medication effects
and overall quality of life11.
The overall high performance of this questionnaire in
its reliability, concurrent and discrimination validity, and
responsiveness to change associated with medical treat-
ment results in its wide use in the English-speaking
countries. However, to conduct multinational epilepsy
studies that include assessments of QOL requires previ-
ous rigorous translation and adaptation of the question-
naire to the culture of each country in which it is going to
be used.13 Such instruments will allow researchers to ag-
gregate and compare QOL data across sample popula-
tions from different countries. The process is compli-
cated not only due to wide differences in the concept of
what constitutes »health« among different cultures but
also due to difficulty in achieving conceptual equivalence
and consistency with the original instrument14. During
last few years, the validations of the Spanish, German,
French, Italian, Thai and Czech versions of QOLIE-31
have been published15–20. These validations indicate a
high degree of conceptual similarity to the original ver-
sion.
The main objective of presented study was to evaluate
the reliability and validity of the translated and cultur-
ally adapted Croatian version of the QOLIE-31 ques-
tionnaire, with an effort to provide a commonmeasure in
reporting the quality of life of patients with epilepsy in
Croatia.
Patients and Methods
The adaptation process was carried out as outlined by
Beaton et al. and Ware et al.21,22. In the first setting, two
bilingual translators, the mother tongue of whom was
Croatian, produced two independent translations, and fi-
nally a synthesis of these two translations was made. Af-
terwards, eight epileptic patients, ranging in age from 19
to 57 years, with different seizure types, completed the
translated version of QOLIE. The next step was discus-
sion of two neurologist with these patients about specific
items of questionaire in search for problems in terms of
acceptance or difficulties in comprehension. Subjects were
asked to explain their opinion on item precision, clarity
and appropriateness for every presented item and re-
sponse. Our intention was to identify confounding, un-
clear, imprecise or inappropriate items. Patients were en-
couraged to write their comments on the questionnaire.
Considering the results of the presented testing, few
minor corrections of translated text were done. One
translator, being unaware of the concepts studied, back-
-translated the adapted Croatian version into the Eng-
lish language. The expert committee composed of two
neurologists, a translator, a physician from public health-
-preventive medicine department, a psychologist and a
biostatistician further assessed the forward and back
translations, and consensus was achieved on the final
translation. The layout and the images of the final Cro-
atian version were identical to the original instrument.
Patients included in presented study were randomly
chosen from the database of Department of Neurology
Epilepsy Service in Split University Hospital Centre
(UHCS). UHCS is the second largest hospital in Croatia,
with 1620 hospital beds, and more than 3500 employees.
There is no other hospital, and also none epileptogist in
private practice in the coverage area of our hospital
(Split-Dalmatian County). General practitioners in Cro-
atia would exclusively rely on specialist services at hospi-
tals for diagnosis and follow-up of all patients with epi-
lepsy. So, the patients included in this study were assu-
med to be representative for the population of epilepsy
patients in Split-Dalmatian County (474.700 inhabit-
ants).
Patients with at least 2 years of follow-up were in-
cluded in the study. The reason for that criterion was to
apply the instrument on patients with their treatments
already established and who are thought to be stable in
terms of their disease. Other eligibility criteria were good
knowledge of Croatian language and ability to read and
write. Exclusion criterion was any serious cognitive dys-
function and coexistence of major psychiatric disease.
Before the interview, all the patients were assessed by an
experienced epileptologist regarding the type, onset, du-
ration and frequency of the seizures during previous
year, including number and type of medications. Data
(including age, gender, and level of education) were re-
corded on the previously designated questionnaire. Co-
morbidity was assessed by the medical record review,
noting existence of other neurologic, musculoskeletal,
cardiovascular, respiratory, hepatic, renal, gastrointesti-
I. Lu{i} et al.: Psychometric Validation of the Croatian QOLIE-31, Coll. Antropol. 35 (2011) 4: 1177–1184
1178
nal, genitourinary, metabolic, hematologic and psychiat-
ric diseases; as well as surgical history and data about
drug reactions.
Analysis of variance (ANOVA) was used to examine
the correlation between QOLIE-31 and demographic and
clinical variables (age, gender, level of education, type,
duration and frequency of seizure(s) during previous
year, duration of epilepsy, type and number of medica-
tions), as well as to assess construct validity under the
hypothesis that duration
of epilepsy, number of medications, type and fre-
quency of seizures would be significantly related to QO-
LIE-31 domains. Patients were divided into five groups
according to seizure frequency: no seizure during last
year, <3 seizures during last year, 4–10 seizures during
last year, 1–2 seizure/month, >3 seizure/month. The hy-
pothesis was that higher seizure frequency would corre-
spond with worse quality of life. Values less than 0.05
were considered statistically significant (adjusted for
multiple testing).
After the interview and a description of study, the
first package was given during their regular control vis-
its to 200 outpatients, which comprised a written short
description of the study, consent form, Croatian version
of QOLIE-31 questionnaire and Short Form-36 (SF-36)
questionnaire. Questionnaires were administered in
face-to-face interviews to check the comprehensibility of
the instruments.
The SF-36 Health Survey is a multi-purpose, short-
-form health survey that consists of 36 questions. It rep-
resents a theoretically based and empirically verified
operationalization of two general health concepts – phys-
ical and psychological, and their two general manifesta-
tions – functioning and well-being. The Croatian version
of SF-36 questionnaire was licensed to »Andrija [tam-
par« School of Public Health23,24. Previously mentioned
QOLIE-89 questionnaire is an QOL measure for people
with epilepsy that includes SF-36 as a generic core, while
QOLIE-31 is a subset of disease targeted items from
QOLIE-8910.
Hundred and seventy two patients (86%) have com-
pleted the first set of questionnaires. The same set of
questionnaries – without the consent form, but with an
addressed and stamped return envelope – were mailed to
the same 172 patients 3–5 weeks after the first one. Hun-
dred and fourteen of the above mentioned first-time re-
spondents (66%) returned their second survey.
Sociodemographic and clinical characteristics of these
114 patients are shown in Table 1.
The average response time between the first and sec-
ond assessments was 26 days.
The two measures of reliability – internal consistency
and reproducibility – were determined by Cronbach a
statistics and intraclass correlation coefficient (ICC), re-
spectively.
Concurrent validity was measured by comparing with
an already translated and validated SF-36 questionnaire.
Although the SF-36 is not a gold standard for health sta-
tus assessment in epilepsy, we decided to use it as a
standard for HRQOL, because it was the only appropri-
ate instrument translated (and validated) in the Cro-
atian language. A possible objection is that we have eval-
uated only a convergent validity – instead of a concurrent
validity. However, the core SF-36 questionnaire has docu-
mented responsiveness in many other diseases besides
epilepsy.
Measurements were made by using the Pearson corre-
lation coefficient (r). Only the internal consistency of the
domains was evaluated for the second part of the study
by using Cronbach a statistics. Statistical Package for
Social Sciences for Windows, version 10.0 (SPSS Inc.,
Chicago, IL, USA) was used for data processing. Values of
p<0.05 were considered statistically significant.
Results
Most of the patients accepted the questionnaire quite
well, and none of the items were found embarrassing.
The time needed to complete the questionnaire was ap-
proximately 18 minutes (11–40); median time for question-
naire completion was 16 minutes. Six patients reported
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TABLE 1
SOCIODEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF
THE STUDY PARTICIPANTS (N=114)
Characteristics Number Percent




Mean duration of epilepsy (yr) 11.3 (range 2–31)
Type of seizure
Simple partial 17 15%
Complex partial 51 45%
Primary generalized 40 35%
Other 6 5%








Primary schoool 14 13%
Industrial or trade school 31 27%
Secondary school 33 29%






difficulty with understanding the meaning of item No. 28
(»social limitations«) and three patients had similar diffi-
culties with the item No. 29 (»physical effects of anti-
epileptic medication«).
Disease duration, frequency of seizures and number
of medications had a significant inverse relationship
with QOLIE-31 scores (p<0.05). Age, gender difference,
type of seizure and level of education were not associated
with QOLIE-31 scores (p>0.05).
Table 2 shows the distribution of scores for the seven
QOLIE-31 domains according to the second part of the
study, with mean scores ranging from 55 to 84. In all of
the domains of QOLIE-31 questionnaire the percentage
of patients with floor effect was less than 2%. The per-
centage of patients with ceiling effect was found to be
high in the seizure worry, medication effect, cognitive
and social functioning domains of QOLIE-31 question-
naire. On two of the seven scales, >30% of the subjects
scored 100 (the maximum value), indicating that a mod-
erate proportion of the patients in our population had a
good QOL – or the questionnaire was unable to discrimi-
nate between these subjects. The standard deviations
were large for all scales, indicating large variations in the
sample on most scales.
For comparison purposes the QOLIE-31 domain sco-
res were analyzed by distribution in quartiles (Table 3).
It was observed that 50% of the patients in role-physical
and role-emotional domains of SF-36 questionnaire sco-
red 100, demonstrating that the spread in the distribu-
tion of the responses was weak in these domains.
In Table 4 the internal consistency reliability scores ac-
cording to the second part of the study are shown. The cal-
culated Cronbach a of internal consistency for two domains
(seizure worry 0.84, medication effects 0.80) was very satis-
factory (Cronbach a=0.80–0.89), and for other five do-
mains (overall quality of life 0.65, emotional well-being
0.73, energy/fatigue 0.76, cognitive functioning 0.71, social
functioning 0.77) was good (Cronbach a= 0.50–0.79).
The domains in SF-36 questionnaire demonstrated
very satisfactory (three domains) or good (five domains)
internal consistency reliability.
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TABLE 2
MEAN QOLIE-31 DOMAIN SCORES (N=114)
Domain/subscale (No of items) Domain means (SD) % with floor effect % with ceiling effect
Seizure worry (5) 76.2 (25.6) 0.9 35.7
Overal QOL (2) 72.6 (21.1) 0.9 11.3
Emotional well-being (5) 77.1 (22.1) 0.0 18.3
Energy/fatigue (4) 54.8 (23.4) 1.7 5.2
Cognitive functioning (6) 62.4 (31.2) 0.9 32.2
Medication effect (3) 75.8 (19.9) 1.7 25.2
Social functioning (5) 84.4 (28.9) 0.9 21.8
TABLE 3

















100% 100 100 96 96 100 100 100
75% 100 96 80 84 100 100 80
50% 90 84 76 76 75 65 60
25% 76 72 68 64 60 60 40


















100% 100 100 100 100 100 100 100 100
75% 90 100 100 90 75 100 75 76
50% 80 100 100 77.5 65 87.5 60 64
25% 72 50 50 57.5 50 62.5 40 56
0% 22 0 0 22.5 15 25 15 20
The test/retest reproducibility correlations are pre-
sented in Table 5. The intraclass correlation coefficient
of six domains of QOLIE-31 questionnaire demonstrated
excellent test/retest reproducibility (ICC  0.75), and good
test/retest reproducibility (ICC  0.40) in one domain
(cognitive functioning). All of the domains of SF-36 ques-
tionnaire demonstrated excellent test/retest reproduci-
bility.
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TABLE 4





Seizure worry 0.84 Physical functioning 0.79
Overal QOL 0.65 Role-physical 0.77
Emotional well-being 0.73 Role-emotional 0.78
Energy/fatigue 0.76 Bodily pain index 0.86
Cognitive functioning 0.71 Vitality 0.74
Medication effect 0.80 Social functioning 0.78
Social functioning 0.77 General health perceptions 0.82
Mental health index 0.81
TABLE 5
TEST–RETEST REPRODUCIBILITY AS DETERMINED BY INTRACLASS CORRELATION COEFFICIENT (N=114)
QOLIE-31 domain ICC SF-36 domain ICC
Seizure worry 0.85 Physical functioning 0.84
Overal QOL 0.77 Role-physical 0.75
Emotional well-being 0.76 Role-emotional 0.83
Energy/fatigue 0.78 Bodily pain index 0.83
Cognitive functioning 0.71 Vitality 0.79
Medication effect 0.81 Social functioning 0.80
Social functioning 0.79 General health perceptions 0.78
Mental health index 0.83
TABLE 6
CONCURRENT VALIDITY OF QOLIE-31 DOMAINS WITH RELEVANT SF-36 DOMAINS AS DETERMINED BY PEARSON CORRELATION
COEFFICIENTS (N=114)
QUOLIE-31 domain SF-36 domain Pearson r p
Seizure worry Role-emotional 0.47 p=0.003
Social functioning 0.57 p=0.000
General health perceptions 0.66 p=0.000
Overal QOL Vitality 0.59 p=0.000
Social functioning 0.42 p=0.004
General health perceptions 0.77 p=0.000
Emotional well-being Role-emotional 0.71 p=0.000
Mental health index 0.55 p=0.000
Energy/fatigue Physical functioning 0.59 p=0.000
Vitality 0.73 p=0.000
General health perceptions 0.65 p=0.000
Cognitive functioning Social functioning 0.40 p=0.008
Mental health index 0.66 p=0.000
Medication effect Physical functioning 0.82 p=0.000
Vitality 0.63 p=0.000
General health perceptions 0.59 p=0.000
Social functioning Social functioning 0.83 p=0.000
Concurrent validity according to the comparison with
the SF-36 questionnaire is shown in Table 6. Correla-
tions were found to be statistically significant among
related domains and generally demonstrated good in 11
domains (r=0.50–0.75) to moderate correlation in 3 do-
mains (r=0.25–0.50). Three domains (overal QOL vs.
general health perception, medication effect vs. physical
functioning and social functioning vs. social functioning)
had excellent correlation (r=0.75–1).
Discussion
In general assessment of epilepsy patients in Croatia,
quality of life measures are underutilized. Currently, out-
come assessment is focused on efficacy – e.g. reduction of
seizures. The objective of this study was to investigate
the validation of the translated and adapted QOLIE-31
questionnaire in 114 Croatian epilepsy patients.
Linguistic adaptation of QOLIE-31 questionnaire was
done, and its reliability and validity for Croatian patients
were evaluated. In the first part of the study, the con-
struction validity and reliability were found to be satis-
factory. Some minor corrections were made in the struc-
ture of questions. As Croatian patients with epilepsy are
not allowed to drive unless they have been seizure-free
for the past 2 years after stopping medication (which
means that practically none of the patients included was
allowed to drive), the item regarding driving (Question
20, Social function subdomain) was modified into more
general – or more broader – question about transporta-
tion problems: »…troubles in order to inability for driv-
ing and for necessity to use public transportation«. Item
28 (Social limitations) was also slightly modified, because
the structure of the question may not reflect the main is-
sue in the way it is desired to ask and may lead to misun-
derstandings for Croatian patients. The stem of the ques-
tion has been thought to be difficult to understand for
our patients, and its perception in its original formmight
be influenced by cultural differences. Consenquently, the
stem has been changed as »Limitations in social activi-
ties – like visiting friends, relatives, etc.« for a precise un-
derstanding.
Generally, the Croatian version of QOLIE-31 ques-
tionnaire was well accepted by the participants. The wide
range of score distribution among patients enrolled in
this study has shown that each patient can interpret his
(or her) social and medical condition in his/her individual
way, indicating that this questionnaire can respond to a
variety of patient-perceived outcomes.
The fact that on two scales more than 30% of the sub-
jects scored the maximum value, indicating that a mod-
erate proportion of the patients in our population had a
good QOL, is hard to explain. The possible explanation
was that all patients included in the study were from the
Dalmatian coastal area, the region of Croatia with out-
standing life conditions. Namely, the first comparative
research on the quality of life of Croatian citizens in com-
parison to citizens of 27 European Union countries, or-
ganised by the United Nations Development Programme
(UNDP) and European Foundation for the Improvement
of Living and Working Conditions (EuroFoundation) ha-
ve shown that life satisfaction, feeling of happiness and
the number of satisfied and happy respondents is the
highest exactly in Split-Dalmatian County. In spite of
economic difficulties, the level of optimism and expecta-
tions for the future in Split-Dalmatian County is among
the highest in Europe; it is higher only in Scandinavian
countries25.
The presence of evident ceiling effect for the seizure
worry, cognitive functioning and medication effect do-
mains may be explained by the trust of the patients to
their treatment in our hospital, and consenquently their
biased answers – since the neurologists who performed
the study were mainly the same who regularly have
treated them from the moment of first diagnosis of epi-
lepsy.
The mean of the Cronbach a values obtained from
Croatian version of QOLIE-31 questionnaire was found
to be slightly lower than the mean of the Cronbach a of
the original version, except in domains of seizure worry
and medication effects. This tendency has been observed
in some other linguistic adaptations of questionnaires,
particularly for the overall QOL domain.
Majority of scales show very good internal consis-
tency, with a Cronbach’s alpha greater than 0.8, except
for Overall QOL, which was slightly lower in comparison
with other domains. This can probably be explained by
the small number of items (two) in the scale. The ten-
dency for slightly lower internal consistency in compari-
son with the original version for some domains could be
interpreted as to be due to undetected cultural differ-
ences (American vs. Croatian) rather than the incorrect
translation of the original questionnaries. The two func-
tion questions with the lowest internal consistencies
were questions 12 and 18.
Test-retest reproducibility as determined by intra-
class correlation coefficient in patients who were re-ex-
amined was very satisfactory for every domain, support-
ing the temporal stability of the questionnaire.
Our study also showed strong and significant correla-
tions between corresponding scales of the Croatian ver-
sion of QOLIE-31 and items of the corresponding SF-36
measures, and lower correlations with noncorresponding
items, supporting the construct validity. Comparing QO-
LIE-31 with SF-36 questionnaire might not be the ideal
way to evaluate the validity of the QOLIE-31 question-
naire in this particular patient population, because SF-36
Health Survey is a multi-purpose short-form health sur-
vey, while QOLIE-31 is specifically targeted question-
naire26. However, SF-36 was the only available adapted
health-related QOL questionnaire in the Croatian lan-
guage. The value of general and specific population norms
has also been demonstrated for the SF-36, and some of
the initial descriptive studies using the SF-36 were per-
formed primarily to validate scale scores27. One reason
has been the lack of practical measurement tools appro-
priate for widespread use across diverse populations, and
the SF-36 was constructed to provide a basis for such
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comparisons of results. Some publications have reported
descriptive data for patients with epilepsy28,29.
In spite of the slightly lower precision in comparison
with the original, the Croatian version came out to be a
valuable instrument, suitable as a generic measure of
QOL for patients with epilepsy and a good tool for popu-
lation surveys, where it can be easily administered.
Conclusion
Self report measures are commonly used in clinical
practice and in research studies. Most existing question-
naires were developed in English and it is not clear how
many have been adapted to other languages. For any
health-related quality of life questionnaire to be used
across cultures, the items must not only be translated
well linguistically but must also be culturally adapted to
maintain the content validity of the instrument at a con-
ceptual level across different cultures. This may necessi-
tate several validation studies to ensure and improve
consistency in the content and face validity between
source and target versions of a questionnaire, due to dif-
ficulty in detecting subtle differences in the living habits
of different cultures. Following this first step, it is also
essential to assess whether the adapted questionnaire
has retained the content validity of the original question-
naire. This second step requires an assessment of the
measurement properties of the new questionnaire.
To improve the QOL of persons with epilepsy, the In-
ternational Commission on Outcome Measurement in
Epilepsy has recommended further research into the
HRQOL among persons with epilepsy4. Indeed, epilepto-
logist should be cautious to report patient outcome stud-
ies based on translated QOLIE-31 questionnaire without
proper evaluation in terms of reliability and validity. Al-
though the sample size was relatively small, we suggest
that Croatian version of QOLIE-31 will be a valuable
contribution to outcome measurement in epilepsy pa-
tients, particularly in the context of treatment trials, but
also in a wider research context. Further studies are
needed to assess its responsiveness to change.
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PSIHOMETRIJSKA VALIDACIJA HRVATSKE VERZIJE »QUALITY OF LIFE IN EPILEPSY
INVENTORY« (QOLIE-31)
S A @ E T A K
Osnovni ciljevi prikazanog istra`ivanja bili su prilagodba hrvatske verzije upitnika QOLIE-31 (Quality of Life in Ep-
ilepsy Inventory – 31 items) te procjena njegovih psihometrijskih svojstava. Stoga je izvr{en prijevod, a zatim i una-
tra`ni prijevod izvorne engleske verzije QOLIE-31, nakon ~ega je ekspertno tijelo izvr{ilo sve radnje neophodne za
me|ukulturalnu prilagodbu upitnika. U slijede}em su koraku QOLIE-31 upitnici te ve} ranije validirani SF-36 (Short
Form-36) upitnici podijeljeni pacijenatima s epilepsijom (N=200). Od njih 200, 172 ispitanika (86%) ispunilo je i vratilo
upitnike, nakon ~ega im je upu}en i drugi komplet istih upitnika. 114 pacijenata vratilo je i drugi komplet upitnika.
Dvije mjere pouzdanosti, u vidu unutarnje konzistencije i reproducibilnosti upitnika ispitane su Cronbachovim a-ko-
eficijentom, kao i koeficijentom intraklasne korelacije. Konkurentna valjanost testa odre|ena je usporedbom s SF-36
upitnikom primjenom Pearsonovog koeficijenta korelacije (r). Prikazanim je istra`ivanjem potvr|ena zadovoljavaju}a
unutarnja konzistencija upitnika s visokim vrijednostima Cronbach-a koeficijenta za sve odgovaraju}e domene (strep-
nja zbog napadaja 0,84, u~inci lijekova 0,80, emocionalna dobrobit 0,73, energija /umor 0,76, kognitivno funkcioniranje
0,71, socijalno funkcioniranje 0,77, ukupna kvaliteta `ivota 0,65). Koeficijenti intraklasne korelacije u {est domena
ukazali su na izvrsnu reproducibilnost u retestiranju (ICC  0,75), te na zadovoljavaju}u reproducibilnost u samo jednoj
domeni (ICC 0,71 – kognitivno funkcioniranje). U pogledu konkurentne valjanosti u tri je domene utvr|ena izvrsna
korelacija (r=0,75–1), u 11 domena korelacija je bila zadovoljavaju}a (r=0,50 to 0,75), dok je u preostale tri domene
korelacija bila umjerena (r=0,25–0,50). Prikazano istra`ivanje ukazuje na ~injenicu da primjena istih upitnika u razli-
~itim civilizacijskim sredinama zahtjeva ne samo primjeren lingvisti~ki pristup ve} i kulturolo{ku prilagodbu u cilju
odr`avanja sadr`ajne valjanosti upitnika na pojmovnoj razini me|u razli~itim kulturama. Hrvatska }e verzija QOLIE-31
predstavljati zna~ajan doprinos u procjeni uspje{nosti lije~enja bolesnika s epilepsijom, i to ne samo u kontekstu istra-
`ivanja lijekova, ve} i u {irem smislu istra`ivanja epilepsije.
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